Literature DB >> 16050460

[Criteria for diagnosis of polypoidal choroidal vasculopathy].

.   

Abstract

Diagnostic criteria for polypoidal choroidal vasculopathy were proposed as follows on the basis of fundus examination and/or indocyanine-green angiographic (IA) findings. Definite cases meet at least one of the following criteria: 1. Protruded orange-red elevated lesions are observed by fundus examination. 2. Characteristic polypoidal lesions are seen in IA findings. ing criteria: 1. Only an abnormal vascular network is seen in IA. 2. Recurrent hemorrhagic and/or serous detachments of the retinal pigment epithelium are observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16050460

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  61 in total

1.  Polypoidal choroidal vasculopathy.

Authors:  Fumihiko Mori; Shuichiro Eguchi
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

2.  A comparison of risk factors for age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese patients.

Authors:  Xiao-Li Chen; Qin-Rui Hu; Yu-Jing Bai; Yu Deng; Hai-Wei Wang; Shan Liu; Yin-Lin Wang; Yan-Kun Yue
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-01       Impact factor: 3.117

3.  Choroidal structures in polypoidal choroidal vasculopathy, neovascular age-related maculopathy, and healthy eyes determined by binarization of swept source optical coherence tomographic images.

Authors:  Malini Bakthavatsalam; Danny Siu-Chun Ng; Frank Hiu-Ping Lai; Fang Yao Tang; Mårten Erik Brelén; Chi Wai Tsang; Timothy Yuk-Yau Lai; Carol Yim-Lui Cheung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-02-01       Impact factor: 3.117

4.  Short-term efficacy of intravitreal aflibercept for patients with treatment-naïve polypoidal choroidal vasculopathy.

Authors:  Shigeyuki Ijiri; Kazuhisa Sugiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-13       Impact factor: 3.117

5.  [Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy].

Authors:  Yi Zhang; Jing Yao; Xiao-Hua Wang; Lin Zhao; Li-Jun Wang; Jian-Ming Wang; Ai-Yi Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

6.  Giant non-pulsatile polypoidal choroidal vasculopathy.

Authors:  Elton Lik Tong Tay; Augustinus Laude
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

7.  Association of an age-related maculopathy susceptibility 2 gene variant with the 12-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Shunichiro Nakai; Wataru Matsumiya; Akiko Miki; Shigeru Honda; Makoto Nakamura
Journal:  Jpn J Ophthalmol       Date:  2019-08-02       Impact factor: 2.447

8.  Monozygotic twins with polypoidal choroidal vasuculopathy.

Authors:  Shigeki Machida; Tomomi Takahashi; Norimoto Gotoh; Nagahisa Yoshimura; Takamitsu Fujiwara; Dajiro Kurosaka
Journal:  Clin Ophthalmol       Date:  2010-07-30

9.  Combined cases of polypoidal choroidal vasculopathy and typical age-related macular degeneration.

Authors:  Ichiro Maruko; Tomohiro Iida; Masaaki Saito; Dai Nagayama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03       Impact factor: 3.117

10.  SERPING1 polymorphisms in polypoidal choroidal vasculopathy.

Authors:  Meng Li; Feng Wen; Chengguo Zuo; Xiongze Zhang; Hui Chen; Shizhou Huang; Guangwei Luo
Journal:  Mol Vis       Date:  2010-02-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.